Matrixx settlement stumbles
This article was originally published in The Tan Sheet
Executive Summary
A federal judge in Arizona objects to Matrixx Initiatives' proposed settlement of economic injury claims in 18 class-action filings. The Zicam maker said Sept. 3 it is working to resolve the procedural issues and still expects to finalize the settlement - totaling up to $35,000 (1"The Tan Sheet" Aug. 23, 2010). In an 2order filed Aug. 26, Judge Frederick Martone of the U.S. District Court for the District of Arizona rejects and denies the stipulation and joint request for dismissal without prejudice. Joining the economic injury claims with another case against Matrixx in a Chicago federal court would circumvent an earlier decision by a panel on multidistrict litigation, which rejected centralizing all actions in the Chicago court, Martone says. Scottsdale, Ariz.-based Matrixx faces hundreds of personal injury suits from consumers claiming they suffer anosmia from use of zinc-containing intranasal Zicam swab products
You may also be interested in...
Matrixx Touts Survey Showing Pharmacists Support Zinc Remedies
Matrixx Initiatives furthers its strategy to restore consumer trust in its troubled Zicam brand with a survey showing most pharmacists recommend zinc-based remedies for a cold.
Matrixx Touts Survey Showing Pharmacists Support Zinc Remedies
Matrixx Initiatives furthers its strategy to restore consumer trust in its troubled Zicam brand with a survey showing most pharmacists recommend zinc-based remedies for a cold.
Matrixx Trims Zicam Litigation Load To Focus on Personal Injury Claims
Matrixx Initiatives settles economic injury claims consumers filed about its Zicam nasal products, allowing the firm to focus on personal injury and shareholder litigation also linked to the products